Business Context and Reporting Period
Pavmed Inc., an emerging growth company incorporated in Delaware, filed this Form 8-K on June 25, 2019. The report details a public offering of common stock conducted directly to investors on a best efforts basis without an underwriter.
Key Financial Metrics
- Shares Offered: 1,800,000 shares of common stock.
- Offering Price: $1.00 per share.
- Gross Proceeds: $1,800,000.
- Estimated Net Proceeds: Approximately $1,785,000 after deducting estimated offering expenses.
- Revenue, Profit, and Debt: The filing text does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels.
Material Changes
The primary material event is the execution of subscription agreements for the sale of 1,800,000 shares. This transaction represents a capital raise intended to increase the company's liquidity. The offering was made pursuant to an existing shelf registration statement (Form S-3, No. 333-220549) declared effective in October 2017.
Outlook and Management Commentary
Management expects the offering to close on or about June 25, 2019. The company utilized a best efforts basis for the sale, indicating that the full amount of shares may not have been sold at the time of filing, though the subscription agreements provide for the sale of all offered shares. No specific forward-looking guidance regarding future operations or financial performance is included in this document.
Investor Verification Checklist
- Verify the actual closing date and final number of shares sold, as the offering was on a "best efforts" basis.
- Confirm the final net proceeds after actual offering expenses are deducted.
- Review the attached Form of Subscription Agreement (Exhibit 10.1) for specific covenants and risk allocation terms.
- Check subsequent filings to determine if the capital raised was sufficient to meet the company's operational needs.